In addition, the likelihood of clinically significant cancer increases with increasing serum PSA value, although this is a multifactorial phenomenon, as prostatic hyperplasia is more likely to result in an elevated PSA, and prostatic hyperplasia would decrease the sensitivity of standard biopsy. Here, KLK3 is linked to prostate disorder.